Dan-Yu Lin

1.4k total citations
22 papers, 845 citations indexed

About

Dan-Yu Lin is a scholar working on Infectious Diseases, Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dan-Yu Lin has authored 22 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 5 papers in Health and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dan-Yu Lin's work include SARS-CoV-2 and COVID-19 Research (11 papers), Vaccine Coverage and Hesitancy (5 papers) and COVID-19 Clinical Research Studies (4 papers). Dan-Yu Lin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), Vaccine Coverage and Hesitancy (5 papers) and COVID-19 Clinical Research Studies (4 papers). Dan-Yu Lin collaborates with scholars based in United States, China and Canada. Dan-Yu Lin's co-authors include Deyin Xing, Wei Qin, Wanlong Tan, Rozenn N. Lemaître, Bruce M. Psaty, Donglin Zeng, Trivellore E. Raghunathan, David S. Siscovick, Sheila Weinmann and Susan R. Heckbert and has published in prestigious journals such as JAMA, Diabetes Care and Clinical Infectious Diseases.

In The Last Decade

Dan-Yu Lin

21 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan-Yu Lin United States 12 225 175 168 164 163 22 845
Rui Fan China 17 124 0.6× 165 0.9× 115 0.7× 138 0.8× 161 1.0× 43 740
Danny M. Cohn Netherlands 22 276 1.2× 185 1.1× 195 1.2× 81 0.5× 152 0.9× 66 1.3k
Carsten A. Böger Germany 20 172 0.8× 163 0.9× 273 1.6× 87 0.5× 190 1.2× 58 1.2k
Jiazhong Sun China 17 104 0.5× 247 1.4× 130 0.8× 125 0.8× 165 1.0× 31 1.1k
Haiyu Pang China 17 141 0.6× 170 1.0× 177 1.1× 138 0.8× 289 1.8× 51 894
Xuejuan Jin China 18 359 1.6× 202 1.2× 294 1.8× 104 0.6× 128 0.8× 64 1.2k
Mads D.M. Engelmann Denmark 12 471 2.1× 270 1.5× 247 1.5× 61 0.4× 237 1.5× 23 1.4k
Beatriz Bayés Spain 17 107 0.5× 198 1.1× 252 1.5× 78 0.5× 80 0.5× 44 962
Francisco Veríssimo Veronese Brazil 23 112 0.5× 115 0.7× 267 1.6× 129 0.8× 187 1.1× 55 1.2k
Michael Garshick United States 15 141 0.6× 150 0.9× 149 0.9× 132 0.8× 174 1.1× 74 1.0k

Countries citing papers authored by Dan-Yu Lin

Since Specialization
Citations

This map shows the geographic impact of Dan-Yu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan-Yu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan-Yu Lin more than expected).

Fields of papers citing papers by Dan-Yu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan-Yu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan-Yu Lin. The network helps show where Dan-Yu Lin may publish in the future.

Co-authorship network of co-authors of Dan-Yu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Dan-Yu Lin. A scholar is included among the top collaborators of Dan-Yu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan-Yu Lin. Dan-Yu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yangjianchen, et al.. (2025). Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants. JAMA Internal Medicine. 185(12). 1501–1501. 1 indexed citations
2.
Lin, Dan-Yu, et al.. (2024). Effectiveness of XBB.1.5 Vaccines Against Omicron Subvariants. Medical Research Archives. 12(8). 2 indexed citations
3.
Lin, Dan-Yu, Jianqiao Wang, Kevin J. Anstrom, et al.. (2024). Efficacy of infliximab, abatacept, and cenicriviroc for the treatment of adults hospitalized with COVID-19 pneumonia. International Journal of Infectious Diseases. 146. 107168–107168. 3 indexed citations
4.
Wang, Xiaofeng, et al.. (2023). Effectiveness of Bebtelovimab Against Hospitalization and Death From the Omicron BA.4/BA.5 and BQ.1/BQ.1.1 Subvariants. CHEST Journal. 164(4). 872–874. 1 indexed citations
5.
Lin, Dan-Yu, et al.. (2023). Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections. JAMA Network Open. 6(9). e2335077–e2335077. 25 indexed citations
6.
Lin, Dan-Yu, Donglin Zeng, Yu Gu, Philip R. Krause, & Thomas R. Fleming. (2022). Reliably Assessing Duration of Protection for Coronavirus Disease 2019 Vaccines. The Journal of Infectious Diseases. 226(11). 1863–1866. 3 indexed citations
7.
Wang, Xiaofeng, Joe Zein, Xinge Ji, & Dan-Yu Lin. (2022). Impact of Vaccination, Prior Infection, and Therapy on Omicron Infection and Mortality. The Journal of Infectious Diseases. 227(8). 970–976. 11 indexed citations
8.
Lin, Dan-Yu, Yu Gu, Donglin Zeng, Holly Janes, & Peter B. Gilbert. (2021). Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clinical Infectious Diseases. 74(3). 544–552. 8 indexed citations
9.
Lin, Dan-Yu, Donglin Zeng, & Peter B. Gilbert. (2021). Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) Vaccines. Clinical Infectious Diseases. 73(10). 1927–1939. 16 indexed citations
10.
Lin, Dan-Yu, Donglin Zeng, Devan V. Mehrotra, Lawrence Corey, & Peter B. Gilbert. (2020). Evaluating the Efficacy of Coronavirus Disease 2019 Vaccines. Clinical Infectious Diseases. 73(8). 1540–1544. 11 indexed citations
11.
Zhao, Xiaomiao, Jia Huang, Lili Huang, et al.. (2013). [Study on the facial and body terminal hair growth in women in Guangdong by using modified Ferriman-Gallwey scoring system].. PubMed. 48(6). 427–31. 4 indexed citations
12.
Lange, Leslie A., Christopher S. Carlson, Lucia A. Hindorff, et al.. (2006). Association of Polymorphisms in the CRP Gene With Circulating C-Reactive Protein Levels and Cardiovascular Events. JAMA. 296(22). 2703–2703. 219 indexed citations
13.
Whitsel, Eric A., Edward J. Boyko, Pentti M. Rautaharju, et al.. (2005). Electrocardiographic QT Interval Prolongation and Risk of Primary Cardiac Arrest in Diabetic Patients. Diabetes Care. 28(8). 2045–2047. 39 indexed citations
14.
Combes, Burton, Velimir A. Luketic, Marion G. Peters, et al.. (2004). Prolonged Follow-Up of Patients in the U.S. Multicenter Trial of Ursodeoxycholic Acid for Primary Biliary Cirrhosis. The American Journal of Gastroenterology. 99(2). 264–268. 30 indexed citations
15.
Rea, Thomas D., David S. Siscovick, Bruce M. Psaty, et al.. (2003). Digoxin therapy and the risk of primary cardiac arrest in patients with congestive heart failure. Journal of Clinical Epidemiology. 56(7). 646–650. 10 indexed citations
16.
Lemaître, Rozenn N., David S. Siscovick, Bruce M. Psaty, et al.. (2002). Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest. The American Journal of Medicine. 113(9). 711–716. 32 indexed citations
17.
Heckbert, Susan R., Robert C. Kaplan, Noel S. Weiss, et al.. (2001). Risk of Recurrent Coronary Events in Relation to Use and Recent Initiation of Postmenopausal Hormone Therapy. Archives of Internal Medicine. 161(14). 1709–1709. 65 indexed citations
18.
Rea, Thomas D., Susan R. Heckbert, Robert C. Kaplan, et al.. (2001). Body mass index and the risk of recurrent coronary events following acute myocardial infarction. The American Journal of Cardiology. 88(5). 467–472. 80 indexed citations
19.
Xing, Deyin, et al.. (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population.. PubMed. 61(8). 3272–5. 203 indexed citations
20.
Lemaître, Rozenn N., David S. Siscovick, Trivellore E. Raghunathan, et al.. (1999). Leisure-Time Physical Activity and the Risk of Primary Cardiac Arrest. Archives of Internal Medicine. 159(7). 686–686. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rui Fan Breakdown of academic impact, for papers by Danny M. Cohn Breakdown of academic impact, for papers by Carsten A. Böger Breakdown of academic impact, for papers by Jiazhong Sun Breakdown of academic impact, for papers by Haiyu Pang Breakdown of academic impact, for papers by Xuejuan Jin Breakdown of academic impact, for papers by Mads D.M. Engelmann Breakdown of academic impact, for papers by Beatriz Bayés Breakdown of academic impact, for papers by Francisco Veríssimo Veronese Breakdown of academic impact, for papers by Michael Garshick
Rankless by CCL
2026